SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
684Endocrinology 2001 Mar 1;142(3):992-999 Biotech Jim-3/3/2001
683Proc. Natl. Acad. Sci. USA, Vol. 98, Issue 5, 2843-2848, February 27, 2001 NeurMiljenko Zuanic-3/3/2001
682biz.yahoo.com Neurocrine Biosciences Announces Expansion of NBI-6024 Clinical PMiljenko Zuanic-2/21/2001
681Gao, I think you confusion may stem from missing what potential therapeutin thScott H. Davis-2/15/2001
680Neurocrine Announces Additional Positive Clinical Trial Results In Sedative Actidalroi-2/15/2001
679You guys are confusing me. I can understand VEGF. But I don't know what hegao seng-2/9/2001
678<<have high affinity for the human receptor with Ki's in the range 0.1Miljenko Zuanic-2/8/2001
677Thursday February 8, 7:32 am Eastern Time Press Release SOURCE: Neurocrine Bioscaram(o)uche-2/8/2001
676More on Zopiclone: At the latest SEPR presentation, Southwell again stated thatBiomaven-2/7/2001
675Zopiclone Brand name: Imovane ----------------------------------------------rkrw-2/7/2001
674FYI: Here's 2 abstracts on the racemic zopiclone. Zopiclone. An update orkrw-2/7/2001
673It's not you Rick, my verbiage was circuitous. An NBIX thread lurker who is NeuroInvestment-2/7/2001
672OT to Rick, I'm probably a certifiable wierdo. I'm the lone, semi-durg Scott H. Davis-2/7/2001
671Scott: >> improve a process that already has significant cost savingscaram(o)uche-2/7/2001
670Neuro, Rick & Miljenko - Thanks for this (& many other) exchange. Rick,Scott H. Davis-2/6/2001
669*OT* Daytrading with that amnesia eh? Ten hours, ha! Buys me five, but I don'Mike McFarland-2/4/2001
668For what it is worth, Ambien *does* produce a noticeable effect the morning afteTorben Noerup Nielsen-2/4/2001
667Thanks Harry, <<It seems to me that if you have a longer half life for a Miljenko Zuanic-2/4/2001
666Rick: All of these drugs act on the GABA-A complex at various sites, and TallmaNeuroInvestment-2/4/2001
665Harry: As always, thanks! I have a gut feeling that what you said was importanscaram(o)uche-2/4/2001
664Miljenko: My understanding is that RPR did not pursue a US NDA because of limitNeuroInvestment-2/4/2001
663You are so generous with your thoughts. Thanks. eomkeokalani'nui-2/3/2001
662Wilder, So far NBI-34060 does have better safety profile than Ambient or ZopicMiljenko Zuanic-2/3/2001
661MZ: I heard with interest also the RS question. If the half-life of the singlekeokalani'nui-2/3/2001
660NBIX, 4Q and year-end CC Nothing significantly new. Short note. Insomnia: PII/Miljenko Zuanic-2/2/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News